Alex specializes in the representation of emerging growth companies throughout their lifecycles as well as venture capital investors. Alex’s practice focuses on general corporate counseling, venture capital financings, public offerings, public company representation and mergers and acquisitions. Alex represents a wide variety of companies, including life science companies in the biotechnology, pharmaceutical, medical device, diagnostics and healthcare IT industries and technology companies in the software and consumer internet industries, as well as leading venture capital firms.

Prior to joining Gunderson Dettmer, Alex was a senior associate in WilmerHale’s Boston office, where he counseled life sciences and technology clients on complex corporate transactions and legal matters.